Toxicological Profile and Pharmacokinetics of a Unilamellar Liposomal Vesicle Formulation of Amphotericin B in Rats

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.2.263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics of Liposomal Amphotericin B (Ambisome) in Critically Ill Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Liposomal Amphotericin B

Medical mycology journal
Infectious DiseasesMicrobiology
2005English

Amphotericin B Pharmacokinetics in Humans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1978English

Comparative Pharmacokinetics, Tissue Distributions, and Effects on Renal Function of Novel Polymeric Formulations of Amphotericin B and Amphotericin B-Deoxycholate in Rats

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Population Pharmacokinetics of Conventional and Intermittent Dosing of Liposomal Amphotericin B in Adults: A First Critical Step for Rational Design of Innovative Regimens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

RecurrentCandida albicansVentriculitis Treated With Intraventricular Liposomal Amphotericin B

Case Reports in Infectious Diseases
2015English

Pharmacokinetics of Amphotericin B Colloidal Dispersion in Liver Failure

BMC Pharmacology
2007English

Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex for Treating Invasive Fungal Infections in Hospitalized Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Influence of Liposomal Amphotericin B on CD8 T-Cell Function

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy